Curaleaf rebuts Aurora board rejection, cites 86% premium and 217% ex-cash premium for enhanced bid

Curaleaf Holdings, Inc.

Curaleaf says its enhanced hostile offer for Aurora carries an 86% premium to Aurora's unaffected 30-day VWAP and 217% on an ex-cash basis; the bid is referenced at $5.00 per share.
Aurora's Oct. 14, 2026 Notice of Change again urged rejection; Curaleaf says it is still denied diligence while Aurora signed confidentiality and standstill pacts with other parties.
Curaleaf cites Aurora ATM sales as low as $2.60/share in July 2026 and says Aurora's implied 14.3x 2026 Adjusted EBITDA multiple exceeds Curaleaf's 13.7x (IFRS).
Curaleaf says Aurora's Adjusted EBITDA fell 63% across its last two quarters and questions Fort Capital's contingent fees and lack of supporting analysis in its fairness opinion.
Seaport Research (Oct. 15) and ATB Capital Markets (Oct. 6) are quoted supporting engagement or calling the revised bid favorable for Aurora shareholders.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.